Our data are supported by 2 clinical trials [25, 29] that showed no beneficial effects of IFN-ɣ on sputum culture conversion in drug-sensitive or drug-resistant pulmonary tuberculosis. This evidence concerns the gene IFNA1 and pulmonary tuberculosis.